Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
Jun 01, 2020 13:00 HKT |  |
|
After Scientific Breakthrough: Digid Seeks FDA Approval for Its Rapid Corona Antigen Test
May 30, 2020 10:00 HKT |  |
|
Sino Biopharmaceutical Announces 2020 First Quarterly Results
May 28, 2020 19:59 HKT |  |
|
Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences' COVID-19 Neutralizing Antibodies
May 27, 2020 10:41 HKT | |
|
Novotech and Endpoints to present APAC Clinical Trial webinar series
May 26, 2020 19:00 HKT |  |
|
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration
May 26, 2020 17:16 HKT | |
|
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus
May 20, 2020 18:15 HKT |  |
|
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020
May 20, 2020 16:00 HKT |  |
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting
May 19, 2020 17:50 HKT | |
|
Cyber Company to Supply 50M Health "COVI-PASS(TM)"
May 08, 2020 14:30 HKT |  |
|
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
Apr 28, 2020 19:00 HKT | |
|
Hua Medicine Announces Positive Results in the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)
Apr 27, 2020 09:50 HKT |  |
|
Akeso, Inc. Enjoys Bright Prospects as Favored by the Capital Market
Apr 24, 2020 16:22 HKT | |
|
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts
Apr 24, 2020 10:00 HKT | |
|
Blockchain Holdings Enters into Definitive Agreement for Acquisition of COVID-19 Quarantine Management Product TRACEsafe
Apr 23, 2020 21:00 HKT |  |
|
CStone announces acceptance of its first New Drug Application in mainland China by the National Medical Products Administration
Apr 23, 2020 13:45 HKT | |
|
TOT BIOPHARM Self-Developed Biological Drug TAB008 (Pusintin) Meets Primary Endpoint in Phase III Clinical Trial
Apr 22, 2020 11:08 HKT | |
|
Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate
Apr 21, 2020 06:30 HKT |  |
|
MicroPort CardioFlow Completes Raising New Round of Funds
Apr 16, 2020 16:57 HKT | |
|
Australian CRO Avance Clinical Designated an Essential Service as Strong Demand from Sponsors Continues Amid COVID-19 Crisis
Apr 09, 2020 20:00 HKT |  |
|